{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,11]],"date-time":"2026-03-11T02:29:55Z","timestamp":1773196195585,"version":"3.50.1"},"reference-count":103,"publisher":"Oxford University Press (OUP)","license":[{"start":{"date-parts":[[2026,3,9]],"date-time":"2026-03-09T00:00:00Z","timestamp":1773014400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"funder":[{"DOI":"10.13039\/501100001659","name":"German Research Foundation","doi-asserted-by":"publisher","award":["C6 - 178316478"],"award-info":[{"award-number":["C6 - 178316478"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"German Research Foundation","doi-asserted-by":"publisher","award":["B7 - 222641018"],"award-info":[{"award-number":["B7 - 222641018"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"German Research Foundation","doi-asserted-by":"publisher","award":["522570761"],"award-info":[{"award-number":["522570761"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Hessian Ministry of Science and Research, Arts and Culture","award":["LOEWE1\/16\/519\/03\/09.001 (0009)\/98"],"award-info":[{"award-number":["LOEWE1\/16\/519\/03\/09.001 (0009)\/98"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background and Hypothesis<\/jats:title>\n                    <jats:p>Pre-attentive information processing deficits are associated with poor outcomes in schizophrenia. The auditory mismatch negativity (MMN), observed when an auditory signal changes, is reduced in schizophrenia, related to glutamatergic dysfunction and is considered a response biomarker. We hypothesized that glycine, an N-methyl-d-aspartate receptor (NMDAR) coagonist, could reverse the NMDAR-antagonistic effects of ketamine, which produces schizophrenia-like clinical symptoms and neurophysiological changes.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Study Design<\/jats:title>\n                    <jats:p>Using a placebo-controlled crossover design, this 64-channel electroencephalography (EEG) study assessed psychopathological changes using the Positive and Negative Syndrome Scale (PANSS) and the 5-Dimensional Altered States of Consciousness (5D-ASC) scale in 25 participants. MMN responses to duration (dMMN) and frequency deviant tones, their underlying theta-band activity and sources, P3a, and associations were examined.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Study Results<\/jats:title>\n                    <jats:p>Ketamine induced schizophrenia-like symptoms, and reduced MMN amplitudes, theta power, and P3a. While glycine did not modulate ketamine\u2019s effect on the (time-domain) MMN or P3a amplitude, it did prevent the effect of ketamine on dMMN-associated theta power and phase consistency. The underlying theta power was associated with auditory alterations, and elevated theta activity due to glycine pretreatment predicted a clinically relevant improvement in negative symptoms.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>This is the first study in humans to investigate the effects of glycine on the MMN in the ketamine model of schizophrenia. The results confirm a key role of the glutamate system for pre-attentive auditory processing deficits underlying the symptoms of schizophrenia. From a translational perspective, the MMN and its theta-band signature may serve as biomarkers to identify patients who may benefit from glutamatergic treatment options.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/schbul\/sbaf227","type":"journal-article","created":{"date-parts":[[2025,11,25]],"date-time":"2025-11-25T12:56:40Z","timestamp":1764075400000},"source":"Crossref","is-referenced-by-count":0,"title":["Effects of Glycine on Mismatch Negativity and the Underlying Theta-Band Signature in the Ketamine Model of Schizophrenia in Healthy Men"],"prefix":"10.1093","author":[{"given":"Stjepan","family":"Curic","sequence":"first","affiliation":[{"name":"Psychiatry Neuroimaging Branch, Department of Psychiatry and Psychotherapy, University Medical Center Hamburg-Eppendorf , 20246 Hamburg ,","place":["Germany"]},{"name":"Institute for Sex Research and Forensic Psychiatry, Center of Psychosocial Medicine, University Medical Center Hamburg-Eppendorf , 20246 Hamburg ,","place":["Germany"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Moritz","family":"Haaf","sequence":"additional","affiliation":[{"name":"Psychiatry Neuroimaging Branch, Department of Psychiatry and Psychotherapy, University Medical Center Hamburg-Eppendorf , 20246 Hamburg ,","place":["Germany"]},{"name":"Department of Psychiatry, Mass General Brigham, Harvard Medical School , Boston, MA 02114 ,","place":["United States"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Darius","family":"Zokai","sequence":"additional","affiliation":[{"name":"Psychiatry Neuroimaging Branch, Department of Psychiatry and Psychotherapy, University Medical Center Hamburg-Eppendorf , 20246 Hamburg ,","place":["Germany"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tarik","family":"Korkutan","sequence":"additional","affiliation":[{"name":"Psychiatry Neuroimaging Branch, Department of Psychiatry and Psychotherapy, University Medical Center Hamburg-Eppendorf , 20246 Hamburg ,","place":["Germany"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Saskia","family":"Rusche","sequence":"additional","affiliation":[{"name":"Psychiatry Neuroimaging Branch, Department of Psychiatry and Psychotherapy, University Medical Center Hamburg-Eppendorf , 20246 Hamburg ,","place":["Germany"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jonas","family":"Rauh","sequence":"additional","affiliation":[{"name":"Psychiatry Neuroimaging Branch, Department of Psychiatry and Psychotherapy, University Medical Center Hamburg-Eppendorf , 20246 Hamburg ,","place":["Germany"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christoph","family":"Mulert","sequence":"additional","affiliation":[{"name":"Psychiatry Neuroimaging Branch, Department of Psychiatry and Psychotherapy, University Medical Center Hamburg-Eppendorf , 20246 Hamburg ,","place":["Germany"]},{"name":"Center for Psychiatry and Psychotherapy, Justus Liebig University , 35392 Gie\u00dfen ,","place":["Germany"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gregor","family":"Leicht","sequence":"additional","affiliation":[{"name":"Psychiatry Neuroimaging Branch, Department of Psychiatry and Psychotherapy, University Medical Center Hamburg-Eppendorf , 20246 Hamburg ,","place":["Germany"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2026,3,9]]},"reference":[{"key":"2026031001415821800_ref1","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1016\/S0166-2236(00)01790-2","article-title":"\u2018Primitive intelligence\u2019 in the auditory cortex","volume":"24","author":"N\u00e4\u00e4t\u00e4nen","year":"2001","journal-title":"Trends Neurosci"},{"key":"2026031001415821800_ref2","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1038\/372090a0","article-title":"Attentive novelty detection in humans is governed by pre-attentive sensory memory","volume":"372","author":"Tiitinen","year":"1994","journal-title":"Nature."},{"key":"2026031001415821800_ref3","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.jpsychires.2021.09.034","article-title":"Decreased mismatch negativity and elevated frontal-lateral connectivity in first-episode psychosis","volume":"144","author":"Y\u00fcksel","year":"2021","journal-title":"J Psychiatr Res"},{"key":"2026031001415821800_ref4","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1111\/j.1469-8986.2007.00602.x","article-title":"Influence of cognitive control and mismatch on the N2 component of the ERP: a review","volume":"45","author":"Folstein","year":"2008","journal-title":"Psychophysiology."},{"key":"2026031001415821800_ref5","doi-asserted-by":"publisher","first-page":"532","DOI":"10.1016\/j.tics.2009.09.003","article-title":"Modeling the auditory scene: predictive regularity representations and perceptual objects","volume":"13","author":"Winkler","year":"2009","journal-title":"Trends Cogn Sci"},{"key":"2026031001415821800_ref6","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1002\/wps.20624","article-title":"Nonsocial and social cognition in schizophrenia: current evidence and future directions","volume":"18","author":"Green","year":"2019","journal-title":"World Psychiatry"},{"key":"2026031001415821800_ref7","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.schres.2004.12.002","article-title":"Mismatch negativity in schizophrenia: a meta-analysis","volume":"76","author":"Umbricht","year":"2005","journal-title":"Schizophr Res"},{"key":"2026031001415821800_ref8","doi-asserted-by":"publisher","first-page":"980","DOI":"10.1016\/j.biopsych.2015.08.025","article-title":"A meta-analysis of mismatch negativity in schizophrenia: from clinical risk to disease specificity and progression","volume":"79","author":"Erickson","year":"2016","journal-title":"Biol Psychiatry"},{"key":"2026031001415821800_ref9","doi-asserted-by":"publisher","DOI":"10.3389\/fpsyt.2020.629144","article-title":"Deficits in pre-attentive processing of spatial location and negative symptoms in subjects at clinical high risk for schizophrenia. Front","volume":"11","author":"Sehatpour","year":"2021","journal-title":"Psychiatry."},{"key":"2026031001415821800_ref10","doi-asserted-by":"publisher","first-page":"108570","DOI":"10.1016\/j.biopsycho.2023.108570","article-title":"Reduced duration mismatch negativity elicited by the multi-feature \u2018optimal\u2019 paradigm in early-phase psychosis","volume":"180","author":"Riel","year":"2023","journal-title":"Biol Psychol"},{"key":"2026031001415821800_ref11","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/j.schres.2016.07.014","article-title":"The dysconnection hypothesis (2016)","volume":"176","author":"Friston","year":"2016","journal-title":"Schizophr Res"},{"key":"2026031001415821800_ref12","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1016\/j.euroneuro.2014.03.008","article-title":"Negative symptoms of schizophrenia: clinical characteristics, pathophysiological substrates, experimental models and prospects for improved treatment","volume":"24","author":"Millan","year":"2014","journal-title":"Eur Neuropsychopharmacol"},{"key":"2026031001415821800_ref13","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1038\/npp.2011.181","article-title":"From revolution to evolution: the glutamate hypothesis of schizophrenia and its implication for treatment","volume":"37","author":"Moghaddam","year":"2012","journal-title":"Neuropsychopharmacology."},{"key":"2026031001415821800_ref14","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/j.schres.2017.05.031","article-title":"The effects of glycine on auditory mismatch negativity in schizophrenia","volume":"191","author":"Greenwood","year":"2018","journal-title":"Schizophr Res"},{"key":"2026031001415821800_ref15","doi-asserted-by":"publisher","first-page":"1601797","DOI":"10.3389\/fphar.2025.1601797","article-title":"Glutamatergic mechanisms in early salience processing","volume":"16","author":"Liesa Lockhofen","year":"2025","journal-title":"Front Pharmacol"},{"key":"2026031001415821800_ref16","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1503\/jpn.160187","article-title":"Glutamatergic deficit and schizophrenia-like negative symptoms: new evidence from ketamine-induced mismatch negativity alterations in healthy male humans","volume":"42","author":"Thiebes","year":"2017","journal-title":"J Psychiatry Neurosci"},{"key":"2026031001415821800_ref17","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.pbb.2021.173287","article-title":"N-methyl-d-aspartate receptor antagonism modulates P300 event-related potentials and associated activity in salience and central executive networks","volume":"211","author":"de la Salle","year":"2021","journal-title":"Pharmacol Biochem Behav"},{"key":"2026031001415821800_ref18","doi-asserted-by":"publisher","first-page":"1239","DOI":"10.1038\/s41386-019-0328-5","article-title":"Reduced auditory evoked gamma-band response and schizophrenia-like clinical symptoms under subanesthetic ketamine","volume":"44","author":"Curic","year":"2019","journal-title":"Neuropsychopharmacology."},{"key":"2026031001415821800_ref19","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1016\/j.bpsc.2018.07.003","article-title":"Selective prefrontal disinhibition in a roving auditory oddball paradigm under N-methyl-D-aspartate receptor blockade","volume":"4","author":"Rosch","year":"2019","journal-title":"Biol Psychiatry Cogn Neurosci Neuroimaging"},{"key":"2026031001415821800_ref20","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.schres.2017.06.023","article-title":"Mismatch negativity as a biomarker of theta band oscillatory dysfunction in schizophrenia","volume":"191","author":"Javitt","year":"2018","journal-title":"Schizophr Res"},{"key":"2026031001415821800_ref21","doi-asserted-by":"publisher","first-page":"935","DOI":"10.1007\/s00429-020-02044-3","article-title":"Dissociation of somatostatin and parvalbumin interneurons circuit dysfunctions underlying hippocampal theta and gamma oscillations impaired by amyloid \u03b2 oligomers in vivo","volume":"225","author":"Chung","year":"2020","journal-title":"Brain Struct Funct"},{"key":"2026031001415821800_ref22","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12915-019-0732-7","article-title":"Optogenetic activation of parvalbumin and somatostatin interneurons selectively restores theta-nested gamma oscillations and oscillation-induced spike timing-dependent long-term potentiation impaired by amyloid \u03b2 oligomers","volume":"18","author":"Park","year":"2020","journal-title":"BMC Biol"},{"key":"2026031001415821800_ref23","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1038\/mp.2011.31","article-title":"A critical role for NMDA receptors in parvalbumin interneurons for gamma rhythm induction and behavior","volume":"17","author":"Carlen","year":"2012","journal-title":"Mol Psychiatry"},{"key":"2026031001415821800_ref24","doi-asserted-by":"publisher","first-page":"671007","DOI":"10.3389\/fpsyt.2021.671007","article-title":"Ketamine alters functional gamma and theta resting-state connectivity in healthy humans: implications for schizophrenia treatment targeting the glutamate system","volume":"12","author":"Curic","year":"2021","journal-title":"Front Psychiatry"},{"key":"2026031001415821800_ref25","doi-asserted-by":"publisher","DOI":"10.3389\/fnbeh.2019.00037","article-title":"Differential of frequency and duration mismatch negativity and theta power deficits in first-episode and chronic schizophrenia","volume":"13","author":"Xiong","year":"2019","journal-title":"Front Behav Neurosci"},{"key":"2026031001415821800_ref26","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.ijpsycho.2018.12.014","article-title":"Decomposing the constituent oscillatory dynamics underlying mismatch negativity generation in schizophrenia: distinct relationships to clinical and cognitive functioning","volume":"145","author":"Hochberger","year":"2019","journal-title":"Int J Psychophysiol"},{"key":"2026031001415821800_ref27","first-page":"1186","article-title":"Mismatch negativity and theta oscillations evoked by auditory deviance in early schizophrenia","volume":"8","author":"Hua","year":"2023","journal-title":"Biol Psychiatry Cogn Neurosci Neuroimaging"},{"key":"2026031001415821800_ref28","doi-asserted-by":"publisher","first-page":"1585","DOI":"10.1038\/mp.2017.3","article-title":"Neural mechanisms of mismatch negativity dysfunction in schizophrenia","volume":"22","author":"Lee","year":"2017","journal-title":"Mol Psychiatry"},{"key":"2026031001415821800_ref29","doi-asserted-by":"publisher","first-page":"468","DOI":"10.3389\/fpsyt.2020.00468","article-title":"Making sense of mismatch negativity","volume":"11","author":"Fitzgerald","year":"2020","journal-title":"Front Psychiatry."},{"key":"2026031001415821800_ref30","doi-asserted-by":"publisher","first-page":"e100221","DOI":"10.1371\/journal.pone.0100221","article-title":"Mismatch negativity in recent-onset and chronic schizophrenia: a current source density analysis","volume":"9","author":"Fulham","year":"2014","journal-title":"PLoS One"},{"key":"2026031001415821800_ref31","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1177\/15500594221089367","article-title":"Temporal and spectral properties of the auditory mismatch negativity and P3a responses in schizophrenia","volume":"54","author":"Lundin","year":"2023","journal-title":"Clin EEG Neurosci"},{"key":"2026031001415821800_ref32","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1016\/S0149-7634(01)00019-7","article-title":"The novelty P3: an event-related brain potential (ERP) sign of the brain's evaluation of novelty","volume":"25","author":"Friedman","year":"2001","journal-title":"Neurosci Biobehav Rev"},{"key":"2026031001415821800_ref33","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1016\/j.jpsychires.2012.12.017","article-title":"Reduced P3a amplitudes in antipsychotic na\u00efve first-episode psychosis patients and individuals at clinical high-risk for psychosis","volume":"47","author":"Mondrag\u00f3n-Maya","year":"2013","journal-title":"J Psychiatr Res"},{"key":"2026031001415821800_ref34","doi-asserted-by":"publisher","DOI":"10.1038\/s41537-021-00146-3","article-title":"Impairment of novelty-related theta oscillations and P3a in never medicated first-episode psychosis patients","volume":"7","author":"Sol\u00eds-Vivanco","year":"2021","journal-title":"NPJ Schizophr"},{"key":"2026031001415821800_ref35","doi-asserted-by":"publisher","first-page":"5838","DOI":"10.3390\/jcm10245838","article-title":"Mismatch negativity and P3a impairment through different phases of schizophrenia and their association with real-life functioning","volume":"10","author":"Giordano","year":"2021","journal-title":"J Clin Med"},{"key":"2026031001415821800_ref36","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1016\/j.schres.2013.08.005","article-title":"Auditory mismatch negativity and P3a in response to duration and frequency changes in the early stages of psychosis","volume":"150","author":"Nagai","year":"2013","journal-title":"Schizophr Res"},{"key":"2026031001415821800_ref37","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/j.schres.2014.09.042","article-title":"Validation of mismatch negativity and P3a for use in multi-site studies of schizophrenia: characterization of demographic, clinical, cognitive, and functional correlates in COGS-2","volume":"163","author":"Light","year":"2015","journal-title":"Schizophr Res"},{"key":"2026031001415821800_ref38","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1017\/S0033291716002518","article-title":"Mismatch negativity and P3a amplitude in young adolescents with first-episode psychosis: a comparison with ADHD","volume":"47","author":"Rydkj\u00e6r","year":"2017","journal-title":"Psychol Med"},{"key":"2026031001415821800_ref39","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1016\/j.schres.2019.02.014","article-title":"P300 as an index of transition to psychosis and of remission: data from a clinical high risk for psychosis study and review of literature","volume":"226","author":"Tang","year":"2020","journal-title":"Schizophr Res"},{"key":"2026031001415821800_ref40","doi-asserted-by":"publisher","first-page":"969","DOI":"10.1016\/j.biopsych.2011.09.031","article-title":"Glutamatergic modulation of auditory information processing in the human brain","volume":"71","author":"Gunduz-Bruce","year":"2012","journal-title":"Biol Psychiatry"},{"key":"2026031001415821800_ref41","doi-asserted-by":"publisher","first-page":"308","DOI":"10.3389\/fnbeh.2018.00308","article-title":"Potential mechanisms for the ketamine-induced reduction of P3b amplitudes","volume":"12","author":"Rosburg","year":"2018","journal-title":"Front Behav Neurosci"},{"key":"2026031001415821800_ref42","doi-asserted-by":"publisher","DOI":"10.3389\/fnbeh.2018.00070","article-title":"Effects of subanesthetic ketamine administration on visual and auditory event-related potentials (ERP) in humans: a systematic review","volume":"12","author":"Schwertner","year":"2018","journal-title":"Front Behav Neurosci"},{"key":"2026031001415821800_ref43","doi-asserted-by":"publisher","first-page":"293","DOI":"10.2174\/1389201019666180620112528","article-title":"Glutamatergic deficits in schizophrenia - biomarkers and pharmacological interventions within the ketamine model","volume":"19","author":"Haaf","year":"2018","journal-title":"Curr Pharm Biotechnol"},{"key":"2026031001415821800_ref44","doi-asserted-by":"publisher","first-page":"1385","DOI":"10.1093\/schbul\/sbaa184","article-title":"A role for somatostatin-positive interneurons in neuro-oscillatory and information processing deficits in schizophrenia","volume":"47","author":"Van Derveer","year":"2020","journal-title":"Schizophr Bull"},{"key":"2026031001415821800_ref45","doi-asserted-by":"publisher","first-page":"1637","DOI":"10.1007\/s00702-019-02080-2","article-title":"Pre-frontal parvalbumin interneurons in schizophrenia: a meta-analysis of post-mortem studies","volume":"126","author":"Kaar","year":"2019","journal-title":"J Neural Transm"},{"key":"2026031001415821800_ref46","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1038\/s41398-021-01763-3","article-title":"mGluR5 binding changes during a mismatch negativity task in a multimodal protocol with [11C]ABP688 PET\/MR-EEG","volume":"12","author":"R\u00e9gio Brambilla","year":"2022","journal-title":"Transl Psychiatry"},{"key":"2026031001415821800_ref47","doi-asserted-by":"publisher","first-page":"195","DOI":"10.5455\/bcp.20140918102748","article-title":"Glycine reuptake inhibitors in the treatment of negative symptoms of schizophrenia","volume":"24","author":"Thomas","year":"2014","journal-title":"Klinik Psikofarmakol B\u00fclteni"},{"key":"2026031001415821800_ref48","doi-asserted-by":"publisher","first-page":"e0119258","DOI":"10.1371\/journal.pone.0119258","article-title":"Relationships among parvalbumin-immunoreactive neuron density, phase-locked gamma oscillations, and autistic\/schizophrenic symptoms in PDGFR-beta knock-out and control mice","volume":"10","author":"Nakamura","year":"2015","journal-title":"PLoS One"},{"key":"2026031001415821800_ref49","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1001\/archpsyc.56.1.29","article-title":"Efficacy of high-dose glycine in the treatment of enduring negative symptoms of schizophrenia","volume":"56","author":"Heresco-Levy","year":"1999","journal-title":"Arch Gen Psychiatry"},{"key":"2026031001415821800_ref50","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1016\/S0006-3223(03)00707-8","article-title":"High-dose glycine added to olanzapine and risperidone for the treatment of schizophrenia","volume":"55","author":"Heresco-Levy","year":"2004","journal-title":"Biol Psychiatry"},{"key":"2026031001415821800_ref51","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1016\/S2215-0366(20)30513-7","article-title":"Efficacy and safety of the novel glycine transporter inhibitor BI 425809 once daily in patients with schizophrenia: a double-blind, randomised, placebo-controlled phase 2 study","volume":"8","author":"Fleischhacker","year":"2021","journal-title":"Lancet Psychiatry"},{"key":"2026031001415821800_ref52","doi-asserted-by":"publisher","first-page":"1387","DOI":"10.1016\/j.clinph.2015.10.062","article-title":"The effects of ketamine on the mismatch negativity (MMN) in humans - a meta-analysis","volume":"127","author":"Rosburg","year":"2016","journal-title":"Clin Neurophysiol"},{"key":"2026031001415821800_ref53","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1016\/j.biopsych.2007.02.016","article-title":"Deviant matters: duration, frequency, and intensity deviants reveal different patterns of mismatch negativity reduction in early and late schizophrenia","volume":"63","author":"Todd","year":"2008","journal-title":"Biol Psychiatry"},{"key":"2026031001415821800_ref54","doi-asserted-by":"publisher","DOI":"10.3389\/fpsyt.2013.00171","article-title":"Mismatch negativity: translating the potential. Front","volume":"4","author":"Todd","year":"2013","journal-title":"Psychiatry."},{"key":"2026031001415821800_ref55","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1016\/j.schres.2017.02.027","article-title":"Improvement in mismatch negativity generation during d-serine treatment in schizophrenia: correlation with symptoms","volume":"191","author":"Kantrowitz","year":"2018","journal-title":"Schizophr Res"},{"key":"2026031001415821800_ref56","doi-asserted-by":"publisher","first-page":"3281","DOI":"10.1093\/brain\/aww262","article-title":"Neurophysiological mechanisms of cortical plasticity impairments in schizophrenia and modulation by the NMDA receptor agonist D-serine","volume":"139","author":"Kantrowitz","year":"2016","journal-title":"Brain."},{"key":"2026031001415821800_ref57","doi-asserted-by":"publisher","first-page":"119004","DOI":"10.1016\/j.neuroimage.2022.119004","article-title":"Glycine attenuates impairments of stimulus-evoked gamma oscillations in the ketamine model of schizophrenia","volume":"251","author":"Haaf","year":"2022","journal-title":"Neuroimage."},{"key":"2026031001415821800_ref58","doi-asserted-by":"publisher","DOI":"10.3390\/ijms24031913","article-title":"Opposite modulation of the NMDA receptor by glycine and S-ketamine and the effects on resting state EEG gamma activity: new insights into the glutamate hypothesis of schizophrenia","volume":"24","author":"Haaf","year":"2023","journal-title":"Int J Mol Sci"},{"key":"2026031001415821800_ref59","doi-asserted-by":"publisher","first-page":"1608","DOI":"10.1038\/s41386-018-0014-z","article-title":"Alterations in interhemispheric gamma-band connectivity are related to the emergence of auditory verbal hallucinations in healthy subjects during NMDA-receptor blockade","volume":"43","author":"Thiebes","year":"2018","journal-title":"Neuropsychopharmacology."},{"key":"2026031001415821800_ref60","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1016\/S0006-3223(99)00133-X","article-title":"IV glycine and oral d-cycloserine effects on plasma and CSF amino acids in healthy humans","volume":"47","author":"D'Souza","year":"2000","journal-title":"Biol Psychiatry"},{"key":"2026031001415821800_ref61","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1093\/schbul\/13.2.261","article-title":"The Positive and Negative Syndrome Scale (PANSS) for schizophrenia","volume":"13","author":"Kay","year":"1987","journal-title":"Schizophr Bull"},{"key":"2026031001415821800_ref62","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1016\/j.schres.2006.03.021","article-title":"The five-factor model of the Positive and Negative Syndrome Scale II: a ten-fold cross-validation of a revised model","volume":"85","author":"van der Gaag","year":"2006","journal-title":"Schizophr Res"},{"key":"2026031001415821800_ref63","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1055\/s-2007-979351","article-title":"The standardized psychometric assessment of altered states of consciousness (ASCs) in humans","volume":"31","author":"Dittrich","year":"1998","journal-title":"Pharmacopsychiatry."},{"key":"2026031001415821800_ref64","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1016\/j.biopsych.2009.07.033","article-title":"Reduced early auditory evoked gamma-band response in patients with schizophrenia","volume":"67","author":"Leicht","year":"2010","journal-title":"Biol Psychiatry"},{"key":"2026031001415821800_ref65","doi-asserted-by":"publisher","first-page":"156869","DOI":"10.1155\/2011\/156869","article-title":"FieldTrip: open source software for advanced analysis of MEG, EEG, and invasive electrophysiological data","volume":"2011","author":"Oostenveld","year":"2011","journal-title":"Comput Intell Neurosci"},{"key":"2026031001415821800_ref66","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.jneumeth.2003.10.009","article-title":"EEGLAB: an open source toolbox for analysis of single-trial EEG dynamics including independent component analysis","volume":"134","author":"Delorme","year":"2004","journal-title":"J Neurosci Methods"},{"key":"2026031001415821800_ref67","article-title":"MEG & EEG toolbox of Hamburg (METH), Version April 15, 2019","author":"Nolte","year":"2025","journal-title":"Accessed"},{"key":"2026031001415821800_ref68","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1001\/archpsyc.1994.03950030035004","article-title":"Subanesthetic effects of the noncompetitive NMDA antagonist, ketamine, in humans. Psychotomimetic, perceptual, cognitive, and neuroendocrine responses","volume":"51","author":"Krystal","year":"1994","journal-title":"Arch Gen Psychiatry"},{"key":"2026031001415821800_ref69","doi-asserted-by":"publisher","first-page":"e204693","DOI":"10.1001\/jamanetworkopen.2020.4693","article-title":"Association of ketamine with psychiatric symptoms and implications for its therapeutic use and for understanding schizophrenia: a systematic review and meta-analysis","volume":"3","author":"Beck","year":"2020","journal-title":"JAMA Netw Open"},{"key":"2026031001415821800_ref70","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/j.schres.2023.04.017","article-title":"Pavlovian conditioning-induced hallucinations reduce MMN amplitudes for duration but not frequency deviants","volume":"256","author":"Abalo-Rodr\u00edguez","year":"2023","journal-title":"Schizophr Res"},{"key":"2026031001415821800_ref71","doi-asserted-by":"publisher","first-page":"570","DOI":"10.1037\/abn0000506","article-title":"Associations of mismatch negativity with psychotic symptoms and functioning transdiagnostically across psychotic disorders","volume":"129","author":"Donaldson","year":"2020","journal-title":"J Abnorm Psychol"},{"key":"2026031001415821800_ref72","doi-asserted-by":"publisher","first-page":"3","DOI":"10.3389\/fphar.2012.00172","article-title":"Nicotine, auditory sensory memory, and sustained attention in a human ketamine model of schizophrenia: moderating influence of a hallucinatory trait","volume":"3","author":"Knott","year":"2012","journal-title":"Front Pharmacol"},{"key":"2026031001415821800_ref73","doi-asserted-by":"publisher","first-page":"3","DOI":"10.3389\/fpsyt.2014.00003","article-title":"Effects of nicotine on the neurophysiological and behavioral effects of ketamine in humans","volume":"5","author":"Mathalon","year":"2014","journal-title":"Front Psychiatry"},{"key":"2026031001415821800_ref74","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/j.schres.2017.06.040","article-title":"Interactive effects of an N-methyl-d-aspartate receptor antagonist and a nicotinic acetylcholine receptor agonist on mismatch negativity: implications for schizophrenia","volume":"191","author":"Hamilton","year":"2018","journal-title":"Schizophr Res"},{"key":"2026031001415821800_ref75","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1007\/s00213-011-2352-y","article-title":"Inhibition of cerebral type 1 cannabinoid receptors is associated with impaired auditory mismatch negativity generation in the ketamine model of schizophrenia","volume":"218","author":"Roser","year":"2011","journal-title":"Psychopharmacology"},{"key":"2026031001415821800_ref76","doi-asserted-by":"publisher","first-page":"100344","DOI":"10.1016\/j.scog.2025.100344","article-title":"Altered theta band and theta\/beta ratio in mismatch negativity associate with treatment effect in schizophrenia with auditory hallucinations","volume":"40","author":"Guo","year":"2025","journal-title":"Schizophr Res Cogn"},{"key":"2026031001415821800_ref77","doi-asserted-by":"publisher","first-page":"770","DOI":"10.1016\/j.biopsych.2019.10.029","article-title":"The thalamocortical circuit of auditory mismatch negativity","volume":"87","author":"Lakatos","year":"2020","journal-title":"Biol Psychiatry"},{"key":"2026031001415821800_ref78","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2019.00455","article-title":"NMDA receptor antagonist effects on speech-related mismatch negativity and its underlying oscillatory and source activity in healthy humans","volume":"10","author":"de la Salle","year":"2019","journal-title":"Front Pharmacol"},{"key":"2026031001415821800_ref79","doi-asserted-by":"publisher","first-page":"155","DOI":"10.55782\/ane-2007-1643","article-title":"The P3 produced by auditory stimuli presented in a passive and active condition: modulation by visual stimuli","volume":"67","author":"Wronka","year":"2007","journal-title":"Acta Neurobiol Exp (Wars)"},{"key":"2026031001415821800_ref80","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1007\/s00213-007-0976-8","article-title":"Acute high-dose glycine attenuates mismatch negativity (MMN) in healthy human controls","volume":"196","author":"Leung","year":"2008","journal-title":"Psychopharmacology"},{"key":"2026031001415821800_ref81","doi-asserted-by":"publisher","first-page":"2128","DOI":"10.1016\/j.clinph.2007.04.019","article-title":"Updating P300: an integrative theory of P3a and P3b","volume":"118","author":"Polich","year":"2007","journal-title":"Clin Neurophysiol"},{"key":"2026031001415821800_ref82","doi-asserted-by":"publisher","first-page":"105221","DOI":"10.1016\/j.neubiorev.2023.105221","article-title":"Dopaminergic and norepinephrinergic modulation of endogenous event-related potentials: a systematic review and meta-analysis","volume":"151","author":"Warren","year":"2023","journal-title":"Neurosci Biobehav Rev"},{"key":"2026031001415821800_ref83","article-title":"Striatal dopamine modulates temporal surprise P3a","author":"Whitaker","year":"2024","journal-title":"bioRxiv [preprint]."},{"key":"2026031001415821800_ref84","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1016\/j.biopsycho.2010.09.003","article-title":"Auditory hallucinations and the P3a: attention-switching to speech in schizophrenia","volume":"85","author":"Fisher","year":"2010","journal-title":"Biol Psychol"},{"key":"2026031001415821800_ref85","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1016\/j.celrep.2016.06.037","article-title":"Somatostatin interneurons control a key component of mismatch negativity in mouse visual cortex","volume":"16","author":"Hamm","year":"2016","journal-title":"Cell Rep"},{"key":"2026031001415821800_ref86","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1073\/pnas.1719523115","article-title":"Somatostatin and parvalbumin inhibitory synapses onto hippocampal pyramidal neurons are regulated by distinct mechanisms","volume":"115","author":"Horn","year":"2018","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2026031001415821800_ref87","doi-asserted-by":"publisher","first-page":"108415","DOI":"10.1016\/j.celrep.2020.108415","article-title":"Somatostatin neurons govern theta oscillations induced by salient visual signals","volume":"33","author":"Huang","year":"2020","journal-title":"Cell Rep"},{"key":"2026031001415821800_ref88","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1038\/npp.2017.176","article-title":"Rodent mismatch negativity\/theta neuro-oscillatory response as a translational neurophysiological biomarker for N-methyl-d-aspartate receptor-based new treatment development in schizophrenia","volume":"43","author":"Lee","year":"2018","journal-title":"Neuropsychopharmacology."},{"key":"2026031001415821800_ref89","doi-asserted-by":"publisher","first-page":"1411","DOI":"10.1038\/s41386-020-0697-9","article-title":"A roadmap for development of neuro-oscillations as translational biomarkers for treatment development in neuropsychopharmacology","volume":"45","author":"Javitt","year":"2020","journal-title":"Neuropsychopharmacology."},{"key":"2026031001415821800_ref90","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1016\/j.schres.2023.08.033","article-title":"Spectral and phase-coherence correlates of impaired auditory mismatch negativity (MMN) in schizophrenia: a MEG study","volume":"261","author":"Sauer","year":"2023","journal-title":"Schizophr Res"},{"key":"2026031001415821800_ref91","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-031-07121-8","volume-title":"EEG-fMRI: Physiological Basis, Technique, and Applications","author":"Mulert","year":"2023"},{"key":"2026031001415821800_ref92","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1002\/wps.20693","article-title":"Dopamine and glutamate in schizophrenia: biology, symptoms and treatment","volume":"19","author":"McCutcheon","year":"2020","journal-title":"World Psychiatry"},{"key":"2026031001415821800_ref93","doi-asserted-by":"publisher","first-page":"901","DOI":"10.1186\/s12888-024-06314-w","article-title":"Effect of antipsychotic on mismatch negativity amplitude and evoked theta power in drug-na\u00efve patients with schizophrenia","volume":"24","author":"Xiong","year":"2024","journal-title":"BMC Psychiatry"},{"key":"2026031001415821800_ref94","doi-asserted-by":"publisher","DOI":"10.3389\/fpsyt.2020.00369","article-title":"Glycine signaling in the framework of dopamine-glutamate interaction and postsynaptic density. Implications for treatment-resistant schizophrenia","volume":"11","author":"de Bartolomeis","year":"2020","journal-title":"Front Psychiatry."},{"key":"2026031001415821800_ref95","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1016\/bs.apha.2016.01.006","article-title":"The NMDA receptor and schizophrenia: from pathophysiology to treatment","volume":"76","author":"Balu","year":"2016","journal-title":"Adv Pharmacol"},{"key":"2026031001415821800_ref96","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/j.schres.2022.01.013","article-title":"The glutamate\/N-methyl-d-aspartate receptor (NMDAR) model of schizophrenia at 35: on the path from syndrome to disease","volume":"242","author":"Javitt","year":"2022","journal-title":"Schizophr Res"},{"key":"2026031001415821800_ref97","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/j.neubiorev.2020.03.010","article-title":"Sex differences in the glutamate system: implications for addiction","volume":"113","author":"Giacometti","year":"2020","journal-title":"Neurosci Biobehav Rev"},{"key":"2026031001415821800_ref98","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1007\/s00213-006-0409-0","article-title":"Greater vulnerability to the amnestic effects of ketamine in males","volume":"187","author":"Morgan","year":"2006","journal-title":"Psychopharmacology"},{"key":"2026031001415821800_ref99","doi-asserted-by":"publisher","DOI":"10.4172\/2155-6105.1000324","article-title":"An assessment of five (PANSS, SAPS, SANS, NSA-16, CGI-SCH) commonly used symptoms rating scales in schizophrenia and comparison to newer scales (CAINS, BNSS)","volume":"08","author":"Kumari","year":"2017","journal-title":"J Addict Res Ther"},{"key":"2026031001415821800_ref100","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1007\/978-3-031-07121-8_5","volume-title":"EEG-fMRI: Physiological Basis, Technique, and Applications","author":"Mulert","year":"2023"},{"key":"2026031001415821800_ref101","doi-asserted-by":"publisher","first-page":"10","DOI":"10.2174\/1874104501004010010","article-title":"Glycine transport inhibitors for the treatment of schizophrenia","volume":"4","author":"Hashimoto","year":"2010","journal-title":"Open Med Chemistry J"},{"key":"2026031001415821800_ref102","doi-asserted-by":"publisher","first-page":"1719","DOI":"10.1016\/j.cell.2024.02.026","article-title":"Transport mechanism and pharmacology of the human GlyT1","volume":"187","author":"Wei","year":"2024","journal-title":"Cell."},{"key":"2026031001415821800_ref103","doi-asserted-by":"publisher","first-page":"1052","DOI":"10.1038\/s41386-023-01560-0","article-title":"The D-amino acid oxidase inhibitor luvadaxistat improves mismatch negativity in patients with schizophrenia in a randomized trial","volume":"48","author":"O\u2019Donnell","year":"2023","journal-title":"Neuropsychopharmacology."}],"container-title":["Schizophrenia Bulletin"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/schizophreniabulletin\/advance-article-pdf\/doi\/10.1093\/schbul\/sbaf227\/65879075\/sbaf227.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/schizophreniabulletin\/advance-article-pdf\/doi\/10.1093\/schbul\/sbaf227\/65879075\/sbaf227.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,10]],"date-time":"2026-03-10T05:42:05Z","timestamp":1773121325000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/schizophreniabulletin\/advance-article\/doi\/10.1093\/schbul\/sbaf227\/8379799"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,9]]},"references-count":103,"URL":"https:\/\/doi.org\/10.1093\/schbul\/sbaf227","relation":{},"ISSN":["0586-7614","1745-1701"],"issn-type":[{"value":"0586-7614","type":"print"},{"value":"1745-1701","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,9]]},"article-number":"sbaf227"}}